Literature DB >> 30176386

Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?

Shenmiao Yang1, Robert Peter Gale2, Hongxia Shi1, Yanrong Liu1, Yueyun Lai1, Jin Lu1, Xiaojun Huang3.   

Abstract

BACKGROUND: Chronic lymphocytic leukaemia (CLL) is 10- to 20-fold less common in Asians (including Han Chinese) compared with persons of predominately European descent. Why is unknown but seems predominately genetic. We observed an increasing frequency of new cases of CLL at our Haematology Centre beginning 2011 and wondered why.
OBJECTIVE: Determine the cause(s) for this increased frequency.
METHOD: We interrogated the context of CLL diagnosis in 483 consecutive subjects seen at the Institute of Haematology of a large referral hospital in Beijing. 3 cohorts were considered based on why a CBC was done to establish the CLL diagnosis: (1) a CBC-testing situation unrelated to a health condition such as a routine annual health exam or application for employment or medical insurance (termed routine CBC); (2) an unrelated medical condition such as a cold, influenza, heart disease etc. (termed CBC for other disorders); and (3) signs and/or symptoms consistent with CLL such as lymph-adenopathy, hepato- or splenomegaly, fatigue, B-symptoms etc. (termed CBC for possible CLL).
RESULTS: Data regarding context of CLL diagnosis were available for 389 subjects (81%). Proportions of subjects in the 3 cohorts were 44% (95% confidence interval [CI]; 39, 49%), 24% (20, 28%) and 32% (28, 37%). The proportion of subjects whose evaluation of CLL was prompted by an abnormal CBC not for possible CLL (cohorts 1 and 2) increased over the surveillance interval (r = 0.164; P = 0.001) as did median age at diagnosis (r = 0.207; P < 0.001). Age at diagnosis was correlated with probability of CLL being suspected because of an abnormal routine CBC (r = 0.249; P < 0.001); 42% (32, 53%) amongst subjects ≤50 years versus 86% (75, 92%; P < 0.001) among those >70 years. Consistent with this, older subjects were diagnosed at Rai stage-0 with asymptomatic disease compared with younger subjects (P < 0.001).
CONCLUSION: Our data suggest much of the increased frequency of CLL at our centre and likely elsewhere in China predominately reflects ascertainment bias. Other variables may also operate.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asia; Chronic lymphocytic leukaemia; Incidence

Mesh:

Year:  2018        PMID: 30176386     DOI: 10.1016/j.leukres.2018.08.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

2.  IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xiao Mao; Min Xiao; Ying Wang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

Review 3.  Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.

Authors:  Leah Moubadder; Lauren E McCullough; Christopher R Flowers; Jean L Koff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

4.  Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH/BCL3 Rearrangements: Report of Three Chinese Cases and Literature Review.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xia Mao; Min Xiao; Jia Wei; Ying Wang
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

5.  Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea.

Authors:  Jun Ho Yi; Gyeong-Won Lee; Ji Hyun Lee; Kwai Han Yoo; Chul Won Jung; Dae Sik Kim; Jeong-Ok Lee; Hyeon Seok Eom; Ja Min Byun; Youngil Koh; Sung Soo Yoon; Jin Seok Kim; Jee Hyun Kong; Ho-Young Yhim; Deok-Hwan Yang; Dok Hyun Yoon; Do Hyoung Lim; Won-Sik Lee; Ho-Jin Shin
Journal:  Blood Res       Date:  2021-12-31

6.  BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.

Authors:  Lu Liu; Xianfeng Cheng; Hui Yang; Senlin Lian; Yuegen Jiang; Jinhua Liang; Xiao Chen; Suo Mo; Yu Shi; Sishu Zhao; Jianyong Li; Runqiu Jiang; Dong-Hua Yang; Yujie Wu
Journal:  Mol Cancer       Date:  2022-02-22       Impact factor: 27.401

7.  CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis.

Authors:  Zijuan Wu; Danling Gu; Ruixin Wang; Xiaoling Zuo; Huayuan Zhu; Luqiao Wang; Xueying Lu; Yi Xia; Shuchao Qin; Wei Zhang; Wei Xu; Lei Fan; Jianyong Li; Hui Jin
Journal:  Exp Hematol Oncol       Date:  2022-09-05

8.  Validation of the Chinese EORTC chronic lymphocytic leukaemia module - application of classical test theory and item response theory.

Authors:  Dong Dong; Jun Jin; Simone Oerlemans; Siyue Yu; Shenmiao Yang; Jianfeng Zhu; Richard Huan Xu
Journal:  Health Qual Life Outcomes       Date:  2020-04-07       Impact factor: 3.186

9.  Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study.

Authors:  Jiadai Xu; Jing Li; Zheng Wei; Yue Wang; Peng Liu
Journal:  BMJ Open       Date:  2020-09-15       Impact factor: 2.692

10.  New kid on the block: C-reactive protein-to-albumin ratio as a new prognostic marker for chronic lymphocytic leukemia: Comment on "C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases".

Authors:  Selin Küçükyurt; Furkan Bahar; Ahmet Emre Eşkazan
Journal:  Transl Oncol       Date:  2021-08       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.